{"results": [{"id": "0001048477:2011:FY", "start_date": "2011-01-01", "end_date": "2011-12-31", "filing_date": "2012-02-22", "timeframe": "annual", "fiscal_period": "FY", "fiscal_year": "2011", "cik": "0001048477", "sic": "2834", "tickers": ["BMRN"], "company_name": "BIOMARIN PHARMACEUTICAL INC", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001193125-12-072924", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001193125-12-072924/files/bmrn-20111231.xml", "financials": {"cash_flow_statement": {"net_cash_flow_from_operating_activities": {"value": 18753000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities": {"value": -89560000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities_continuing": {"value": 18753000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow": {"value": -41807000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities_continuing": {"value": 29000000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_continuing": {"value": -41807000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities": {"value": 29000000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities_continuing": {"value": -89560000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}}, "comprehensive_income": {"other_comprehensive_income_loss": {"value": -49137000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -49137000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -49137000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}}, "balance_sheet": {"equity": {"value": 773048000.0, "unit": "USD", "label": "Equity", "order": 1400}, "noncurrent_assets": {"value": 833879000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "noncurrent_liabilities": {"value": 436508000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "other_than_fixed_noncurrent_assets": {"value": 564908000.0, "unit": "USD", "label": "Other Than Fixed Noncurrent Assets", "order": 500}, "liabilities": {"value": 530633000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity_attributable_to_parent": {"value": 773048000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "liabilities_and_equity": {"value": 1303681000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "fixed_assets": {"value": 268971000.0, "unit": "USD", "label": "Fixed Assets", "order": 400}, "current_liabilities": {"value": 94125000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "assets": {"value": 1303681000.0, "unit": "USD", "label": "Assets", "order": 100}, "current_assets": {"value": 469802000.0, "unit": "USD", "label": "Current Assets", "order": 200}}, "income_statement": {"operating_income_loss": {"value": -33890000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "costs_and_expenses": {"value": 475248000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "income_loss_from_continuing_operations_after_tax": {"value": -53836000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "income_tax_expense_benefit": {"value": 10209000.0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "net_income_loss_available_to_common_stockholders_basic": {"value": -53836000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "net_income_loss": {"value": -53836000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "gross_profit": {"value": 357335000.0, "unit": "USD", "label": "Gross Profit", "order": 800}, "benefits_costs_expenses": {"value": 484985000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "operating_expenses": {"value": 391225000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "income_tax_expense_benefit_current": {"value": 5846000.0, "unit": "USD", "label": "Income Tax Expense/Benefit, Current", "order": 2300}, "interest_expense_operating": {"value": 8349000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "net_income_loss_attributable_to_parent": {"value": -53836000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "cost_of_revenue": {"value": 84023000.0, "unit": "USD", "label": "Cost Of Revenue", "order": 300}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "income_tax_expense_benefit_deferred": {"value": 4363000.0, "unit": "USD", "label": "Income Tax Expense/Benefit, Deferred", "order": 2400}, "income_loss_from_equity_method_investments": {"value": -2426000.0, "unit": "USD", "label": "Income/Loss From Equity Method Investments", "order": 2100}, "revenues": {"value": 441358000.0, "unit": "USD", "label": "Revenues", "order": 100}, "diluted_earnings_per_share": {"value": -0.48, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "basic_earnings_per_share": {"value": -0.48, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "income_loss_from_continuing_operations_before_tax": {"value": -43627000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "income_loss_before_equity_method_investments": {"value": -43627000.0, "unit": "USD", "label": "Income/Loss Before Equity Method Investments", "order": 1300}}}}, {"id": "0001048477:2012:FY", "start_date": "2012-01-01", "end_date": "2012-12-31", "filing_date": "2013-02-26", "timeframe": "annual", "fiscal_period": "FY", "fiscal_year": "2012", "cik": "0001048477", "sic": "2834", "tickers": ["BMRN"], "company_name": "BIOMARIN PHARMACEUTICAL INC", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001193125-13-077031", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001193125-13-077031/files/bmrn-20121231.xml", "financials": {"balance_sheet": {"noncurrent_liabilities": {"value": 415447000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "liabilities_and_equity": {"value": 1601643000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "noncurrent_assets": {"value": 858181000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "assets": {"value": 1601643000.0, "unit": "USD", "label": "Assets", "order": 100}, "fixed_assets": {"value": 284473000.0, "unit": "USD", "label": "Fixed Assets", "order": 400}, "liabilities": {"value": 585880000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "other_than_fixed_noncurrent_assets": {"value": 573708000.0, "unit": "USD", "label": "Other Than Fixed Noncurrent Assets", "order": 500}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "current_liabilities": {"value": 170433000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity": {"value": 1015763000.0, "unit": "USD", "label": "Equity", "order": 1400}, "equity_attributable_to_parent": {"value": 1015763000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "current_assets": {"value": 743462000.0, "unit": "USD", "label": "Current Assets", "order": 200}}, "income_statement": {"preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "income_loss_from_continuing_operations_after_tax": {"value": -114347000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "income_loss_from_equity_method_investments": {"value": -1221000.0, "unit": "USD", "label": "Income/Loss From Equity Method Investments", "order": 2100}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "income_tax_expense_benefit_current": {"value": 5990000.0, "unit": "USD", "label": "Income Tax Expense/Benefit, Current", "order": 2300}, "benefits_costs_expenses": {"value": 619001000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "income_loss_from_continuing_operations_before_tax": {"value": -118278000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "income_loss_before_equity_method_investments": {"value": -118278000.0, "unit": "USD", "label": "Income/Loss Before Equity Method Investments", "order": 1300}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "net_income_loss_available_to_common_stockholders_basic": {"value": -114347000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "revenues": {"value": 500723000.0, "unit": "USD", "label": "Revenues", "order": 100}, "cost_of_revenue": {"value": 91830000.0, "unit": "USD", "label": "Cost Of Revenue", "order": 300}, "gross_profit": {"value": 408893000.0, "unit": "USD", "label": "Gross Profit", "order": 800}, "income_tax_expense_benefit_deferred": {"value": -9921000.0, "unit": "USD", "label": "Income Tax Expense/Benefit, Deferred", "order": 2400}, "interest_expense_operating": {"value": 7639000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "operating_expenses": {"value": 519108000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "operating_income_loss": {"value": -110215000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "net_income_loss": {"value": -114347000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "income_tax_expense_benefit": {"value": -3931000.0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "diluted_earnings_per_share": {"value": -0.95, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "costs_and_expenses": {"value": 610938000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "basic_earnings_per_share": {"value": -0.95, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "net_income_loss_attributable_to_parent": {"value": -114347000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}}, "cash_flow_statement": {"net_cash_flow_continuing": {"value": 134255000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities_continuing": {"value": -195645000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow": {"value": 134255000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities": {"value": -195645000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities_continuing": {"value": 312291000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities_continuing": {"value": 17609000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_operating_activities": {"value": 17609000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities": {"value": 312291000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -119436000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": -5089000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -119436000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}}}, {"id": "0001048477:2013:FY", "start_date": "2013-01-01", "end_date": "2013-12-31", "filing_date": "2014-02-26", "timeframe": "annual", "fiscal_period": "FY", "fiscal_year": "2013", "cik": "0001048477", "sic": "2834", "tickers": ["BMRN"], "company_name": "BIOMARIN PHARMACEUTICAL INC", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001193125-14-070025", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001193125-14-070025/files/bmrn-20131231.xml", "financials": {"cash_flow_statement": {"net_cash_flow_from_financing_activities": {"value": 746671000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities_continuing": {"value": -59634000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow": {"value": 388254000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities": {"value": -298783000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_continuing": {"value": 388254000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities_continuing": {"value": 746671000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities": {"value": -59634000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities_continuing": {"value": -298783000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -171133000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": 5220000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -171133000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}, "balance_sheet": {"liabilities_and_equity": {"value": 2249217000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "noncurrent_liabilities": {"value": 724905000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "assets": {"value": 2249217000.0, "unit": "USD", "label": "Assets", "order": 100}, "equity": {"value": 1341041000.0, "unit": "USD", "label": "Equity", "order": 1400}, "current_liabilities": {"value": 183271000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity_attributable_to_parent": {"value": 1341041000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "fixed_assets": {"value": 319316000.0, "unit": "USD", "label": "Fixed Assets", "order": 400}, "current_assets": {"value": 1137418000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "liabilities": {"value": 908176000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "other_than_fixed_noncurrent_assets": {"value": 792483000.0, "unit": "USD", "label": "Other Than Fixed Noncurrent Assets", "order": 500}, "noncurrent_assets": {"value": 1111799000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}}, "income_statement": {"income_loss_before_equity_method_investments": {"value": -176503000.0, "unit": "USD", "label": "Income/Loss Before Equity Method Investments", "order": 1300}, "income_loss_from_equity_method_investments": {"value": -1149000.0, "unit": "USD", "label": "Income/Loss From Equity Method Investments", "order": 2100}, "net_income_loss_available_to_common_stockholders_basic": {"value": -176353000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "gross_profit": {"value": 452743000.0, "unit": "USD", "label": "Gross Profit", "order": 800}, "net_income_loss": {"value": -176353000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "operating_income_loss": {"value": -156007000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "income_tax_expense_benefit_current": {"value": 8755000.0, "unit": "USD", "label": "Income Tax Expense/Benefit, Current", "order": 2300}, "cost_of_revenue": {"value": 95742000.0, "unit": "USD", "label": "Cost Of Revenue", "order": 300}, "income_loss_from_continuing_operations_after_tax": {"value": -176353000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "operating_expenses": {"value": 608750000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "benefits_costs_expenses": {"value": 724988000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "income_loss_from_continuing_operations_before_tax": {"value": -176503000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "interest_expense_operating": {"value": 10447000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "revenues": {"value": 548485000.0, "unit": "USD", "label": "Revenues", "order": 100}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "costs_and_expenses": {"value": 704492000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "income_tax_expense_benefit_deferred": {"value": -9156000.0, "unit": "USD", "label": "Income Tax Expense/Benefit, Deferred", "order": 2400}, "net_income_loss_attributable_to_parent": {"value": -176353000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "income_tax_expense_benefit": {"value": -150000, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}}}}, {"id": "0001048477:2014:FY", "start_date": "2014-01-01", "end_date": "2014-12-31", "filing_date": "2015-03-02", "timeframe": "annual", "fiscal_period": "FY", "fiscal_year": "2014", "cik": "0001048477", "sic": "2834", "tickers": ["BMRN"], "company_name": "BIOMARIN PHARMACEUTICAL INC", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001564590-15-001140", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001564590-15-001140/files/bmrn-20141231.xml", "financials": {"comprehensive_income": {"comprehensive_income_loss": {"value": -111521000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": 22448000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -111521000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}}, "balance_sheet": {"equity": {"value": 1527894000.0, "unit": "USD", "label": "Equity", "order": 1400}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "noncurrent_liabilities": {"value": 726820000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "liabilities": {"value": 962559000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "assets": {"value": 2490453000.0, "unit": "USD", "label": "Assets", "order": 100}, "other_than_fixed_noncurrent_assets": {"value": 541308000.0, "unit": "USD", "label": "Other Than Fixed Noncurrent Assets", "order": 500}, "equity_attributable_to_parent": {"value": 1527894000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "current_liabilities": {"value": 235739000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "current_assets": {"value": 1425629000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "liabilities_and_equity": {"value": 2490453000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "fixed_assets": {"value": 523516000.0, "unit": "USD", "label": "Fixed Assets", "order": 400}, "noncurrent_assets": {"value": 1064824000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}}, "income_statement": {"gross_profit": {"value": 621276000.0, "unit": "USD", "label": "Gross Profit", "order": 800}, "interest_expense_operating": {"value": 36642000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "net_income_loss_attributable_to_parent": {"value": -133969000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "revenues": {"value": 751040000.0, "unit": "USD", "label": "Revenues", "order": 100}, "income_loss_from_continuing_operations_after_tax": {"value": -133969000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "income_loss_from_equity_method_investments": {"value": -877000, "unit": "USD", "label": "Income/Loss From Equity Method Investments", "order": 2100}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "income_tax_expense_benefit": {"value": 9101000.0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "income_tax_expense_benefit_deferred": {"value": -25483000.0, "unit": "USD", "label": "Income Tax Expense/Benefit, Deferred", "order": 2400}, "income_loss_from_continuing_operations_before_tax": {"value": -124868000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "costs_and_expenses": {"value": 843931000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "benefits_costs_expenses": {"value": 875908000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "operating_expenses": {"value": 714167000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "income_loss_before_equity_method_investments": {"value": -124868000.0, "unit": "USD", "label": "Income/Loss Before Equity Method Investments", "order": 1300}, "operating_income_loss": {"value": -92891000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "cost_of_revenue": {"value": 129764000.0, "unit": "USD", "label": "Cost Of Revenue", "order": 300}, "income_tax_expense_benefit_current": {"value": 34718000.0, "unit": "USD", "label": "Income Tax Expense/Benefit, Current", "order": 2300}, "net_income_loss_available_to_common_stockholders_basic": {"value": -133969000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "net_income_loss": {"value": -133969000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}}, "cash_flow_statement": {"net_cash_flow": {"value": 306705000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_continuing": {"value": 306705000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities": {"value": 185689000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities": {"value": 194555000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities_continuing": {"value": 185689000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities_continuing": {"value": -73539000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_operating_activities": {"value": -73539000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities_continuing": {"value": 194555000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}}}}, {"id": "0001048477:2015:FY", "start_date": "2015-01-01", "end_date": "2015-12-31", "filing_date": "2016-02-29", "timeframe": "annual", "fiscal_period": "FY", "fiscal_year": "2015", "cik": "0001048477", "sic": "2834", "tickers": ["BMRN"], "company_name": "BIOMARIN PHARMACEUTICAL INC", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001564590-16-013653", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001564590-16-013653/files/bmrn-20151231.xml", "financials": {"comprehensive_income": {"comprehensive_income_loss": {"value": -178232000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": -6433000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -178232000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}}, "income_statement": {"income_tax_expense_benefit": {"value": 17075000.0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "net_income_loss": {"value": -171799000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "net_income_loss_attributable_to_parent": {"value": -171799000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "income_loss_from_continuing_operations_after_tax": {"value": -171799000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "cost_of_revenue": {"value": 152008000.0, "unit": "USD", "label": "Cost Of Revenue", "order": 300}, "income_tax_expense_benefit_deferred": {"value": -76827000.0, "unit": "USD", "label": "Income Tax Expense/Benefit, Deferred", "order": 2400}, "revenues": {"value": 889895000.0, "unit": "USD", "label": "Revenues", "order": 100}, "operating_expenses": {"value": 848589000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "operating_income_loss": {"value": -110702000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "net_income_loss_available_to_common_stockholders_basic": {"value": -171799000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "benefits_costs_expenses": {"value": 1044619000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "costs_and_expenses": {"value": 1000597000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "income_loss_from_continuing_operations_before_tax": {"value": -154724000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "income_loss_from_equity_method_investments": {"value": -817000, "unit": "USD", "label": "Income/Loss From Equity Method Investments", "order": 2100}, "gross_profit": {"value": 737887000.0, "unit": "USD", "label": "Gross Profit", "order": 800}, "income_loss_before_equity_method_investments": {"value": -154724000.0, "unit": "USD", "label": "Income/Loss Before Equity Method Investments", "order": 1300}, "interest_expense_operating": {"value": 38244000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "income_tax_expense_benefit_current": {"value": 93902000.0, "unit": "USD", "label": "Income Tax Expense/Benefit, Current", "order": 2300}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}}, "balance_sheet": {"current_liabilities": {"value": 445457000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity": {"value": 2400847000.0, "unit": "USD", "label": "Equity", "order": 1400}, "liabilities": {"value": 1328521000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "liabilities_and_equity": {"value": 3729368000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "noncurrent_assets": {"value": 2639729000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "current_assets": {"value": 1089639000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "other_than_fixed_noncurrent_assets": {"value": 1935522000.0, "unit": "USD", "label": "Other Than Fixed Noncurrent Assets", "order": 500}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "noncurrent_liabilities": {"value": 883064000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "assets": {"value": 3729368000.0, "unit": "USD", "label": "Assets", "order": 100}, "fixed_assets": {"value": 704207000.0, "unit": "USD", "label": "Fixed Assets", "order": 400}, "equity_attributable_to_parent": {"value": 2400847000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}}, "cash_flow_statement": {"net_cash_flow_from_operating_activities_continuing": {"value": -221689000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities_continuing": {"value": -1179598000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_investing_activities": {"value": -1179598000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "exchange_gains_losses": {"value": -5072000.0, "unit": "USD", "label": "Exchange Gains/Losses", "order": 1000}, "net_cash_flow": {"value": -478446000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities": {"value": -221689000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities_continuing": {"value": 927913000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_continuing": {"value": -473374000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities": {"value": 927913000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}}}}, {"id": "0001048477:2016:FY", "start_date": "2016-01-01", "end_date": "2016-12-31", "filing_date": "2017-02-27", "timeframe": "annual", "fiscal_period": "FY", "fiscal_year": "2016", "cik": "0001048477", "sic": "2834", "tickers": ["BMRN"], "company_name": "BIOMARIN PHARMACEUTICAL INC", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001564590-17-002483", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001564590-17-002483/files/bmrn-20161231.xml", "financials": {"income_statement": {"participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "net_income_loss": {"value": -630210000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "revenues": {"value": 1116854000.0, "unit": "USD", "label": "Revenues", "order": 100}, "diluted_earnings_per_share": {"value": -3.81, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "operating_income_loss": {"value": -803429000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "cost_of_revenue": {"value": 209620000.0, "unit": "USD", "label": "Cost Of Revenue", "order": 300}, "income_tax_expense_benefit_current": {"value": 27214000.0, "unit": "USD", "label": "Income Tax Expense/Benefit, Current", "order": 2300}, "operating_expenses": {"value": 1710663000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "income_loss_from_continuing_operations_after_tax": {"value": -630210000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "income_loss_from_continuing_operations_before_tax": {"value": -831050000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "income_tax_expense_benefit": {"value": -200840000.0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "basic_earnings_per_share": {"value": -3.8, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "interest_expense_operating": {"value": 39499000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "benefits_costs_expenses": {"value": 1947904000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "gross_profit": {"value": 907234000.0, "unit": "USD", "label": "Gross Profit", "order": 800}, "income_loss_from_equity_method_investments": {"value": -538000, "unit": "USD", "label": "Income/Loss From Equity Method Investments", "order": 2100}, "income_tax_expense_benefit_deferred": {"value": -228054000.0, "unit": "USD", "label": "Income Tax Expense/Benefit, Deferred", "order": 2400}, "net_income_loss_attributable_to_parent": {"value": -630210000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "income_loss_before_equity_method_investments": {"value": -831050000.0, "unit": "USD", "label": "Income/Loss Before Equity Method Investments", "order": 1300}, "costs_and_expenses": {"value": 1920283000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "net_income_loss_available_to_common_stockholders_basic": {"value": -630210000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}}, "comprehensive_income": {"other_comprehensive_income_loss": {"value": -8217000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -638427000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -638427000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss_attributable_to_parent": {"value": -8217000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss Attributable To Parent", "order": 600}}, "cash_flow_statement": {"net_cash_flow_from_financing_activities_continuing": {"value": 727108000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_financing_activities": {"value": 727108000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_continuing": {"value": 15224000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities_continuing": {"value": -484047000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "exchange_gains_losses": {"value": -3934000.0, "unit": "USD", "label": "Exchange Gains/Losses", "order": 1000}, "net_cash_flow_from_operating_activities_continuing": {"value": -227837000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_operating_activities": {"value": -227837000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow": {"value": 11290000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities": {"value": -484047000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}}, "balance_sheet": {"fixed_assets": {"value": 798768000.0, "unit": "USD", "label": "Fixed Assets", "order": 400}, "equity_attributable_to_parent": {"value": 2766275000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "noncurrent_assets": {"value": 2601899000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "liabilities_and_equity": {"value": 4023690000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "current_assets": {"value": 1421791000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "current_liabilities": {"value": 439310000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "other_than_fixed_noncurrent_assets": {"value": 1803131000.0, "unit": "USD", "label": "Other Than Fixed Noncurrent Assets", "order": 500}, "assets": {"value": 4023690000.0, "unit": "USD", "label": "Assets", "order": 100}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "noncurrent_liabilities": {"value": 818105000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "liabilities": {"value": 1257415000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity": {"value": 2766275000.0, "unit": "USD", "label": "Equity", "order": 1400}}}}, {"id": "0001048477:2017:FY", "start_date": "2017-01-01", "end_date": "2017-12-31", "filing_date": "2018-02-26", "timeframe": "annual", "fiscal_period": "FY", "fiscal_year": "2017", "cik": "0001048477", "sic": "2834", "tickers": ["BMRN"], "company_name": "BIOMARIN PHARMACEUTICAL INC", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001564590-18-003114", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001564590-18-003114/files/bmrn-20171231.xml", "financials": {"income_statement": {"diluted_earnings_per_share": {"value": -0.67, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "gross_profit": {"value": 1071860000.0, "unit": "USD", "label": "Gross Profit", "order": 800}, "income_loss_from_continuing_operations_after_tax": {"value": -117042000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "operating_expenses": {"value": 1086560000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "income_tax_expense_benefit": {"value": 81167000.0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "net_income_loss_attributable_to_parent": {"value": -117042000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "costs_and_expenses": {"value": 1328346000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "basic_earnings_per_share": {"value": -0.67, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "net_income_loss_available_to_common_stockholders_basic": {"value": -117042000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "income_tax_expense_benefit_current": {"value": 36703000.0, "unit": "USD", "label": "Income Tax Expense/Benefit, Current", "order": 2300}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "operating_income_loss": {"value": -14700000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "benefits_costs_expenses": {"value": 1349521000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "income_loss_from_continuing_operations_before_tax": {"value": -35875000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "income_tax_expense_benefit_deferred": {"value": 44464000.0, "unit": "USD", "label": "Income Tax Expense/Benefit, Deferred", "order": 2400}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "revenues": {"value": 1313646000.0, "unit": "USD", "label": "Revenues", "order": 100}, "cost_of_revenue": {"value": 241786000.0, "unit": "USD", "label": "Cost Of Revenue", "order": 300}, "income_loss_from_equity_method_investments": {"value": -1291000.0, "unit": "USD", "label": "Income/Loss From Equity Method Investments", "order": 2100}, "net_income_loss": {"value": -117042000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "interest_expense_operating": {"value": 42707000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "income_loss_before_equity_method_investments": {"value": -35875000.0, "unit": "USD", "label": "Income/Loss Before Equity Method Investments", "order": 1300}}, "cash_flow_statement": {"net_cash_flow_from_investing_activities": {"value": -305459000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities": {"value": 507145000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities": {"value": -8757000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities_continuing": {"value": 507145000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_continuing": {"value": 192929000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "exchange_gains_losses": {"value": -3231000.0, "unit": "USD", "label": "Exchange Gains/Losses", "order": 1000}, "net_cash_flow_from_investing_activities_continuing": {"value": -305459000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow": {"value": 189698000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities_continuing": {"value": -8757000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -152819000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -152819000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss_attributable_to_parent": {"value": -35777000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss Attributable To Parent", "order": 600}, "other_comprehensive_income_loss": {"value": -35777000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}, "balance_sheet": {"equity": {"value": 2808663000.0, "unit": "USD", "label": "Equity", "order": 1400}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "noncurrent_liabilities": {"value": 1007944000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "fixed_assets": {"value": 896700000.0, "unit": "USD", "label": "Fixed Assets", "order": 400}, "current_assets": {"value": 2207144000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "other_than_fixed_noncurrent_assets": {"value": 1529281000.0, "unit": "USD", "label": "Other Than Fixed Noncurrent Assets", "order": 500}, "noncurrent_assets": {"value": 2425981000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "current_liabilities": {"value": 816518000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "liabilities_and_equity": {"value": 4633125000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "assets": {"value": 4633125000.0, "unit": "USD", "label": "Assets", "order": 100}, "liabilities": {"value": 1824462000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity_attributable_to_parent": {"value": 2808663000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}}}}, {"id": "0001048477:2018:FY", "start_date": "2018-01-01", "end_date": "2018-12-31", "filing_date": "2019-02-28", "timeframe": "annual", "fiscal_period": "FY", "fiscal_year": "2018", "cik": "0001048477", "sic": "2834", "tickers": ["BMRN"], "company_name": "BIOMARIN PHARMACEUTICAL INC", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001564590-19-005033", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001564590-19-005033/files/bmrn-20181231.xml", "financials": {"balance_sheet": {"equity": {"value": 2967940000.0, "unit": "USD", "label": "Equity", "order": 1400}, "noncurrent_assets": {"value": 2370913000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "noncurrent_liabilities": {"value": 935947000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "assets": {"value": 4427128000.0, "unit": "USD", "label": "Assets", "order": 100}, "liabilities_and_equity": {"value": 4427128000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "current_assets": {"value": 2056215000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "equity_attributable_to_parent": {"value": 2967940000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "current_liabilities": {"value": 523241000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "fixed_assets": {"value": 948682000.0, "unit": "USD", "label": "Fixed Assets", "order": 400}, "liabilities": {"value": 1459188000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "other_than_fixed_noncurrent_assets": {"value": 1422231000.0, "unit": "USD", "label": "Other Than Fixed Noncurrent Assets", "order": 500}}, "cash_flow_statement": {"net_cash_flow": {"value": -104046000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities": {"value": -388007000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities": {"value": 264351000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_continuing": {"value": -103448000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_operating_activities": {"value": 20208000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities_continuing": {"value": 264351000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities_continuing": {"value": 20208000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "exchange_gains_losses": {"value": -598000, "unit": "USD", "label": "Exchange Gains/Losses", "order": 1000}, "net_cash_flow_from_financing_activities_continuing": {"value": -388007000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -48393000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": 28818000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -48393000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss_attributable_to_parent": {"value": 28818000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss Attributable To Parent", "order": 600}}, "income_statement": {"preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "net_income_loss_attributable_to_parent": {"value": -77211000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "benefits_costs_expenses": {"value": 1633917000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "income_loss_from_equity_method_investments": {"value": -553000, "unit": "USD", "label": "Income/Loss From Equity Method Investments", "order": 2100}, "net_income_loss": {"value": -77211000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "income_tax_expense_benefit_deferred": {"value": -68378000.0, "unit": "USD", "label": "Income Tax Expense/Benefit, Deferred", "order": 2400}, "gross_profit": {"value": 1175948000.0, "unit": "USD", "label": "Gross Profit", "order": 800}, "income_loss_from_continuing_operations_after_tax": {"value": -77211000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "cost_of_revenue": {"value": 315264000.0, "unit": "USD", "label": "Cost Of Revenue", "order": 300}, "income_tax_expense_benefit_current": {"value": 2884000.0, "unit": "USD", "label": "Income Tax Expense/Benefit, Current", "order": 2300}, "operating_expenses": {"value": 1299472000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "diluted_earnings_per_share": {"value": -0.44, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "operating_income_loss": {"value": -123524000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "income_loss_from_continuing_operations_before_tax": {"value": -142705000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "costs_and_expenses": {"value": 1614736000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "income_tax_expense_benefit": {"value": -65494000.0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "net_income_loss_available_to_common_stockholders_basic": {"value": -77211000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "revenues": {"value": 1491212000.0, "unit": "USD", "label": "Revenues", "order": 100}, "income_loss_before_equity_method_investments": {"value": -142705000.0, "unit": "USD", "label": "Income/Loss Before Equity Method Investments", "order": 1300}, "interest_expense_operating": {"value": 43664000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "basic_earnings_per_share": {"value": -0.44, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}}}}, {"id": "0001048477:2019:FY", "start_date": "2019-01-01", "end_date": "2019-12-31", "filing_date": "2020-02-27", "timeframe": "annual", "fiscal_period": "FY", "fiscal_year": "2019", "cik": "0001048477", "sic": "2834", "tickers": ["BMRN"], "company_name": "BIOMARIN PHARMACEUTICAL INC", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001048477-20-000009", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001048477-20-000009/files/bmrn-20191231_htm.xml", "financials": {"balance_sheet": {"current_liabilities": {"value": 932503000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity_attributable_to_parent": {"value": 3122381000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "equity": {"value": 3122381000.0, "unit": "USD", "label": "Equity", "order": 1400}, "fixed_assets": {"value": 1010868000.0, "unit": "USD", "label": "Fixed Assets", "order": 400}, "noncurrent_liabilities": {"value": 635155000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "liabilities_and_equity": {"value": 4690039000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "other_than_fixed_noncurrent_assets": {"value": 1737028000.0, "unit": "USD", "label": "Other Than Fixed Noncurrent Assets", "order": 500}, "current_assets": {"value": 1942143000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "assets": {"value": 4690039000.0, "unit": "USD", "label": "Assets", "order": 100}, "liabilities": {"value": 1567658000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "noncurrent_assets": {"value": 2747896000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}}, "income_statement": {"operating_expenses": {"value": 1445039000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "income_tax_expense_benefit": {"value": -70963000.0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "revenues": {"value": 1704048000.0, "unit": "USD", "label": "Revenues", "order": 100}, "cost_of_revenue": {"value": 359466000.0, "unit": "USD", "label": "Cost Of Revenue", "order": 300}, "net_income_loss_attributable_to_parent": {"value": -23848000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "income_loss_from_continuing_operations_after_tax": {"value": -23848000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "interest_expense_operating": {"value": 23460000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "operating_income_loss": {"value": -100457000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "income_loss_from_continuing_operations_before_tax": {"value": -94811000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss_available_to_common_stockholders_basic": {"value": -23848000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "benefits_costs_expenses": {"value": 1798859000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "income_loss_before_equity_method_investments": {"value": -94811000.0, "unit": "USD", "label": "Income/Loss Before Equity Method Investments", "order": 1300}, "income_tax_expense_benefit_current": {"value": 11797000.0, "unit": "USD", "label": "Income Tax Expense/Benefit, Current", "order": 2300}, "gross_profit": {"value": 1344582000.0, "unit": "USD", "label": "Gross Profit", "order": 800}, "income_loss_from_equity_method_investments": {"value": -587000, "unit": "USD", "label": "Income/Loss From Equity Method Investments", "order": 2100}, "basic_earnings_per_share": {"value": -0.13, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "net_income_loss": {"value": -23848000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "diluted_earnings_per_share": {"value": -0.13, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "income_tax_expense_benefit_deferred": {"value": -82760000.0, "unit": "USD", "label": "Income Tax Expense/Benefit, Deferred", "order": 2400}, "costs_and_expenses": {"value": 1804505000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}}, "comprehensive_income": {"comprehensive_income_loss": {"value": -8955000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": 14893000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -8955000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss_attributable_to_parent": {"value": 14893000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss Attributable To Parent", "order": 600}}, "cash_flow_statement": {"net_cash_flow_from_operating_activities": {"value": 48262000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities_continuing": {"value": -74674000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities": {"value": -31026000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_investing_activities_continuing": {"value": -31026000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow": {"value": -56536000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "exchange_gains_losses": {"value": 902000, "unit": "USD", "label": "Exchange Gains/Losses", "order": 1000}, "net_cash_flow_continuing": {"value": -57438000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities": {"value": -74674000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities_continuing": {"value": 48262000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}}}}, {"id": "0001048477:2020:FY", "start_date": "2020-01-01", "end_date": "2020-12-31", "filing_date": "2021-02-26", "timeframe": "annual", "fiscal_period": "FY", "fiscal_year": "2020", "cik": "0001048477", "sic": "2834", "tickers": ["BMRN"], "company_name": "BIOMARIN PHARMACEUTICAL INC", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001048477-21-000008", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001048477-21-000008/files/bmrn-20201231_htm.xml", "financials": {"income_statement": {"cost_of_revenue": {"value": 524272000.0, "unit": "USD", "label": "Cost Of Revenue", "order": 300}, "net_income_loss": {"value": 859100000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "revenues": {"value": 1860455000.0, "unit": "USD", "label": "Revenues", "order": 100}, "operating_expenses": {"value": 1372948000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "gross_profit": {"value": 1336183000.0, "unit": "USD", "label": "Gross Profit", "order": 800}, "net_income_loss_available_to_common_stockholders_basic": {"value": 859100000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "costs_and_expenses": {"value": 1897220000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "diluted_earnings_per_share": {"value": 4.53, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "income_loss_from_equity_method_investments": {"value": -6000, "unit": "USD", "label": "Income/Loss From Equity Method Investments", "order": 2100}, "income_loss_before_equity_method_investments": {"value": -42322000.0, "unit": "USD", "label": "Income/Loss Before Equity Method Investments", "order": 1300}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "income_loss_from_continuing_operations_before_tax": {"value": -42322000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "net_income_loss_attributable_to_parent": {"value": 859100000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "income_loss_from_continuing_operations_after_tax": {"value": 859100000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "operating_income_loss": {"value": -36765000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "income_tax_expense_benefit": {"value": -901422000.0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "income_tax_expense_benefit_current": {"value": -12515000.0, "unit": "USD", "label": "Income Tax Expense/Benefit, Current", "order": 2300}, "interest_expense_operating": {"value": 29309000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "income_tax_expense_benefit_deferred": {"value": -888907000.0, "unit": "USD", "label": "Income Tax Expense/Benefit, Deferred", "order": 2400}, "benefits_costs_expenses": {"value": 1902777000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "basic_earnings_per_share": {"value": 4.75, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}}, "balance_sheet": {"other_than_fixed_noncurrent_assets": {"value": 2473330000.0, "unit": "USD", "label": "Other Than Fixed Noncurrent Assets", "order": 500}, "current_liabilities": {"value": 492548000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "noncurrent_assets": {"value": 3505801000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "equity_attributable_to_parent": {"value": 4106002000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "assets": {"value": 5848020000.0, "unit": "USD", "label": "Assets", "order": 100}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "liabilities_and_equity": {"value": 5848020000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "fixed_assets": {"value": 1032471000.0, "unit": "USD", "label": "Fixed Assets", "order": 400}, "equity": {"value": 4106002000.0, "unit": "USD", "label": "Equity", "order": 1400}, "noncurrent_liabilities": {"value": 1249470000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "liabilities": {"value": 1742018000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "current_assets": {"value": 2342219000.0, "unit": "USD", "label": "Current Assets", "order": 200}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": 822797000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss_attributable_to_parent": {"value": -36303000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss Attributable To Parent", "order": 600}, "other_comprehensive_income_loss": {"value": -36303000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": 822797000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}}, "cash_flow_statement": {"net_cash_flow_continuing": {"value": 212862000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities": {"value": 181118000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow": {"value": 211712000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities": {"value": -53621000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "exchange_gains_losses": {"value": -1150000.0, "unit": "USD", "label": "Exchange Gains/Losses", "order": 1000}, "net_cash_flow_from_financing_activities_continuing": {"value": 181118000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities_continuing": {"value": 85365000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities_continuing": {"value": -53621000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities": {"value": 85365000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}}}}, {"id": "0001048477:2021:FY", "start_date": "2021-01-01", "end_date": "2021-12-31", "filing_date": "2022-02-25", "timeframe": "annual", "fiscal_period": "FY", "fiscal_year": "2021", "cik": "0001048477", "sic": "2834", "tickers": ["BMRN"], "company_name": "BIOMARIN PHARMACEUTICAL INC", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001048477-22-000012", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001048477-22-000012/files/bmrn-20211231_htm.xml", "financials": {"comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -33509000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -33509000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": 30571000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "other_comprehensive_income_loss_attributable_to_parent": {"value": 30571000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss Attributable To Parent", "order": 600}}, "cash_flow_statement": {"net_cash_flow_continuing": {"value": -61825000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities_continuing": {"value": -48000, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow": {"value": -61882000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities": {"value": -48000, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities": {"value": -366313000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_investing_activities_continuing": {"value": -366313000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "exchange_gains_losses": {"value": -57000, "unit": "USD", "label": "Exchange Gains/Losses", "order": 1000}, "net_cash_flow_from_operating_activities_continuing": {"value": 304536000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_operating_activities": {"value": 304536000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}}, "income_statement": {"gross_profit": {"value": 1375760000.0, "unit": "USD", "label": "Gross Profit", "order": 800}, "net_income_loss_available_to_common_stockholders_basic": {"value": -64080000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "income_tax_expense_benefit": {"value": -11270000.0, "unit": "USD", "label": "Income Tax Expense/Benefit", "order": 2200}, "operating_expenses": {"value": 1458101000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "income_tax_expense_benefit_current": {"value": 4338000.0, "unit": "USD", "label": "Income Tax Expense/Benefit, Current", "order": 2300}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "basic_earnings_per_share": {"value": -0.35, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "interest_expense_operating": {"value": 15337000.0, "unit": "USD", "label": "Interest Expense, Operating", "order": 2700}, "benefits_costs_expenses": {"value": 1921625000.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "income_loss_from_continuing_operations_before_tax": {"value": -75350000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "operating_income_loss": {"value": -82341000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "income_loss_from_continuing_operations_after_tax": {"value": -64080000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "costs_and_expenses": {"value": 1928616000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "net_income_loss_attributable_to_parent": {"value": -64080000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "net_income_loss": {"value": -64080000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "cost_of_revenue": {"value": 470515000.0, "unit": "USD", "label": "Cost Of Revenue", "order": 300}, "income_tax_expense_benefit_deferred": {"value": -15608000.0, "unit": "USD", "label": "Income Tax Expense/Benefit, Deferred", "order": 2400}, "revenues": {"value": 1846275000.0, "unit": "USD", "label": "Revenues", "order": 100}, "diluted_earnings_per_share": {"value": -0.35, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}}, "balance_sheet": {"other_than_fixed_noncurrent_assets": {"value": 2693479000.0, "unit": "USD", "label": "Other Than Fixed Noncurrent Assets", "order": 500}, "equity_attributable_to_parent": {"value": 4270740000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "equity": {"value": 4270740000.0, "unit": "USD", "label": "Equity", "order": 1400}, "current_assets": {"value": 2274385000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "noncurrent_liabilities": {"value": 1192763000.0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "current_liabilities": {"value": 539822000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "liabilities": {"value": 1732585000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "fixed_assets": {"value": 1035461000.0, "unit": "USD", "label": "Fixed Assets", "order": 400}, "liabilities_and_equity": {"value": 6003325000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "assets": {"value": 6003325000.0, "unit": "USD", "label": "Assets", "order": 100}, "noncurrent_assets": {"value": 3728940000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}}}}], "status": "OK", "request_id": "2740e3b1a60c019cfc9093ddefa2d20f"}